With a 60+ year history as a service provider to the life sciences industry, Advanced BioScience Laboratories (ABL) provides a strong core of product development expertise, GMP manufacturing, and testing capabilities. Founded in 1961 as a biomedical research contractor for the federal government, ABL has made major contributions to the development and evaluation of a wide range of life-saving diagnostics, vaccines, and therapeutics designed to combat the worlds most challenging diseases. We partner with our clients to support advancement of their candidate vaccines and therapeutics through preclinical and clinical development. With facilities located in the United States, ABL aims to be a seamless extension of our clients team helping them advance todays ideas into tomorrows medicines. ABL is a subsidiary of the Institut Merieux from Lyon, France. ABL's CDMO service division specializes in the development and manufacturing of GMP cell banks and viral vectors from early stage to market, and contributes to the success of its clients' immunotherapy innovations, including gene therapies, immunotherapies, viral vaccines, recombinant protein vaccines, and more. ABL's CDMO services include bulk drug substance, fill/finish of drug products, process and assay development, and bioanalytical testing.